Abstract
Rationale
Stress, a powerful precipitant of drug seeking during abstinence, may also accelerate the return to pathological patterns of intake after initial instances of drug reuse.
Objective
To explore the effect of stress on a learning process underlying relapse, this study assessed the effect of yohimbine on reacquisition of oxycodone seeking.
Methods
One hundred thirty-two male Sprague–Dawley rats underwent place conditioning with oxycodone (2 mg/kg, SC; ×6 days), extinction (vehicle × 6 days), and reconditioning with 0, 0.25, 2, or 5 mg/kg oxycodone (2 days). Yohimbine (0, 2.5, or 5 mg/kg, IP) was administered 30 min prior to reconditioning.
Results
Pretreatment with 2.5 mg/kg yohimbine increased, while 5 mg/kg yohimbine decreased, reacquisition of oxycodone-induced place preference. A follow-up study (n = 30) further indicated that the effect of yohimbine was specific to reacquisition.
Conclusion
The observation that yohimbine can enhance reacquisition of oxycodone seeking supports the hypothesis that stress can facilitate learning processes involved in the unfolding of relapse.
Similar content being viewed by others
References
Banna KM, Back SE, Do P, See RE (2010) Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats. Behavioural Brain R 208:144–148
Batra VR, Schrott LM (2011) Acute oxycodone induces the pro-emetic pica response in rats. J Pharmacol Exp Ther 339:738–745
Bouton ME (2000) A learning theory perspective on lapse, relapse, and the maintenance of behavior change. Health Psychol 19:57–63
Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, Le DA, O’Dell LE, Overstreet DH, Roberts AJ, Sinha R, Valdez GR, Weiss F (2005) Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29:185–195
Brown ZJ, Tribe E, D’Souza NA, Erb S (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology 203:121–130
Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D’Agata R (1996) The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. J Neuroendocrinol 8:579–585
Carter BL, Tiffany ST (1999) Meta-analysis of cue-reactivity in addiction research. Addiction 94:327–340
Childress AR, Ehrman R, McLellan AT, MacRae J, Natale M, O’Brien CP (1994) Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat 11:17–23
Childress AR, Ehrman R, Rohsenow DJ, Robbins SJ, O’Brien CP, Lowinson JH, Ruiz P, Millman RB (1992) Classically conditioned factors in drug dependence substance abuse: a comprehensive textbook. Williams and Wilkins, Baltimore, pp 56–69
Chopin P, Pellow S, File SE (1986) The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology 25:53–57
Chornock WM, Stitzer ML, Gross J, Leischow S (1992) Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology 108:495–500
Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2008) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 33:1179–1191
Curry SJ, Marlatt GA, Gordon J, Baer JS (1988) A comparison of alternative theoretical approaches to smoking cessation and relapse. Health Psychol 7:545–556
Davis MP, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R (2003) Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 11:84–92
Der-Avakian A, Bland ST, Rozeske RR, Tamblyn JP, Hutchinson MR, Watkins LR, Maier SF (2007) The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats. Psychopharmacology 191:909–917
Dunn KE, Sigmon SC, McGee MR, Heil SH, Higgins ST (2008) Evaluation of ongoing oxycodone abuse among methadone-maintained patients. J Subst Abuse Treat 35:451–456
Le Dzung A, Funk D, Harding S, Juzytsch W, Fletcher PJ (2009) The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. Psychopharmacology 204:477–488
Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128:408–412
Feltenstein MW, See RE (2006) Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res 174:1–8
Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA (2008) The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33:1402–1412
Foltin RW, Haney M (2000) Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacology 149:24–33
Garcin F, Radouco-Thomas S, Tremblay R, Radouco-Thomas C (1977) Experimental narcotic dependence models of primary dependence, abstinence and relapse obtained by intravenous self-administration in rat. Prog Neuropsychopharmacol 1:61–81
Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y (2006) The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology 31:2188–2196
Gossop M, Stewart D, Browne N, Marsden J (2002) Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 97:1259–1267
Grella SL, Levy A, Campbell A, Djazayeri S, Allen CP, Goddard B, Leri F (2011) Oxycodone dose-dependently imparts conditioned reinforcing properties to discrete sensory stimuli in rats. Pharmacol Res 64:364–70
Iwamoto ET (1985) Place-conditioning properties of mu, kappa, and sigma opioid agonists. Alcohol Drug Res 6:327–339
Johnston AL, File SE (1989) Yohimbine’s anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 32:151–156
Kupferschmidt DA, Tribe E, Erb S (2009) Effects of repeated yohimbine on the extinction and reinstatement of cocaine seeking. Pharmacol Biochem Behav 91:473–480
Le AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179:366–373
Leao RM, Cruz FC, Planeta CS (2009) Exposure to acute restraint stress reinstates nicotine-induced place preference in rats. Behav Pharmacol 20:109–113
Leri F, Burns LH (2005) Ultra-low-dose naltrexone reduces rewarding potency of oxycodone and relapse vulnerability in rats. Pharmacol Biochem Behav 82:252–262
Leri F, Franklin KB (2000) Diazepam in the ventral striatum dissociates dopamine-dependent and dopamine-independent place conditioning. Neuroreport 11:2553–2557
Leri F, Rizos Z (2005) Reconditioning of drug-related cues: a potential contributor to relapse after drug reexposure. Pharmacol Biochem Behav 80:621–630
Leri F, Stewart J (2002) The consequences of different lapses on relapse to heroin-seeking in rats. Exp Clin Psychopharmacol 10:339–349
Liu Y, Le FB, Wang X, Lu L (2008) Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement. Sci World J 8:1228–1245
Liu YL, Liang JH, Yan LD, Su RB, Wu CF, Gong ZH (2005) Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice. Acta Pharmacol Sin 26:533–538
Majczynski H, Cabaj A, Slawinska U, Gorska T (2006) Intrathecal administration of yohimbine impairs locomotion in intact rats. Behav Brain Res 175:315–322
Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010) Involvement of noradrenergic neurotransmission in the stress-but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for beta-2 adrenergic receptors. Neuropsychopharmacology 35:2165–2178
Marlatt GA, Gordon JR (1985) Relapse prevention: maintenance strategies in the treatment of addictive behavior. Guilford Press, New York
Martinez-Pinero MG, Milanes MV, Alcaraz C, Vargas ML (1994) Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of alpha- and beta-adrenoceptors. Brain Res 668:122–128
Mason K, Heal DJ, Stanford SC (1998) The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty. Pharmacol Biochem Behav 60:321–327
Moore BA, Budney AJ (2003) Relapse in outpatient treatment for marijuana dependence. J Subst Abuse Treat 25:85–89
Morales L, Perez-Garcia C, Alguacil LF (2001) Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents. Br J Pharmacol 133:172–178
Nielsen CK, Ross FB, Lotfipour S, Saini KS, Edwards SR, Smith MT (2007) Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain 132:289–300
Olmstead MC, Burns LH (2005) Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Psychopharmacology 181:576–581
Ovari J, Leri F (2008) Inactivation of the ventromedial prefrontal cortex mimics re-emergence of heroin seeking caused by heroin reconditioning. Neurosci Lett 444:52–55
Pechnick RN (1993) Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol 33:353–82
Pfeiffer A, Herz A (1984) Endocrine actions of opioids. Horm Metab Res 16:386–397
Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Armario A, Minarro J (2006) Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice. Psychopharmacology 185:459–470
Riley J, Eisenberg E, Muller-Schwefe G, Drewes AM, Arendt-Nielsen L (2008) Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 24:175–192
Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD (2007) Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Dep 90:64–71
Ross FB, Smith MT (1997) The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 73:151–157
Rutten K, van der Kam EL, De Vry J, Tzschentke TM (2011) Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats. Pharmacology 87:286–296
Sahraei H, Ghazzaghi H, Zarrindast MR, Ghoshooni H, Sepehri H, Haeri-Rohan A (2004) The role of alpha-adrenoceptor mechanism(s) in morphine-induced conditioned place preference in female mice. Pharmacol Biochem Behav 78:135–141
Sandi C, Pinelo-Nava MT (2007) Stress and memory: behavioral effects and neurobiological mechanisms. Neural Plast 2007:78970
See RE (2002) Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71:517–529
Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33:13–33
Shaham Y, Shalev U, Lu L, de Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3–20
Shaham Y, Stewart J (1995) Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334–341
Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42
Shalev U, Highfield D, Yap J, Shaham Y (2000) Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology 150:337–346
Shepard JD, Bossert JM, Liu SY, Shaham Y (2004) The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082–1089
Sinha R, Fuse T, Aubin LR, O'Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology 152:140–148
Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324–331
Smythe GA, Bradshaw JE, Vining RF (1983) Hypothalamic monoamine control of stress-induced adrenocorticotropin release in the rat. Endocrinology 113:1062–1071
Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine. E J Pharmacol 34:385–388
Sticht M, Mitsubata J, Tucci M, Leri F (2010) Reacquisition of heroin and cocaine place preference involves a memory consolidation process sensitive to systemic and intra-ventral tegmental area naloxone. Neurobiol Learn Mem 93:248–260
Thompson T, Ostlund W (1965) Susceptibility to readdiction as a function of the addiction and withdrawal environments. J Comp Physiol Psychol 60:388–392
Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS (2000) Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 85:4138–4145
Witkiewitz K, Marlatt GA (2004) Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol 59:224–235
Zarrindast MR, Bahreini T, Adl M (2002) Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav 73:941–949
Acknowledgments
This study was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and by a New Emerging Team Grant (#79919) from the Canadian Institutes of Health Research (CIHR).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campbell, A.T., Kwiatkowski, D., Boughner, E. et al. Effect of yohimbine stress on reacquisition of oxycodone seeking in rats. Psychopharmacology 222, 247–255 (2012). https://doi.org/10.1007/s00213-012-2640-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-012-2640-1